Revolution Medicines Inc.
RVMD | NASDAQ
$191.95
+$1 (+0.52%)
Sep 21, 2026, 1:34 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | n/a | n/a | 11.58M | 35.38M | 29.39M | 42.98M |
Cost of Revenue | 16.56M | n/a | n/a | n/a | n/a | n/a |
Gross Profit | -16.56M | n/a | 11.58M | 35.38M | 29.39M | 42.98M |
Operating Income | -1.18B | -689.52M | -487.19M | -258.28M | -188.01M | -110.7M |
Interest Income | 90.69M | 86.88M | 47.48M | 9.15M | 929K | 2.24M |
Pretax Income | -1.13B | -600.85M | -439.89M | -249.13M | -187.09M | -108.53M |
Net Income | -1.13B | -600.09M | -436.37M | -248.71M | -187.09M | -108.16M |
Selling & General & Admin | 187.13M | 97.3M | 75.62M | 40.59M | 30.45M | 21.43M |
Research & Development | 978.68M | 592.23M | 423.14M | 253.07M | 186.95M | 132.25M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 1.17B | 689.52M | 498.77M | 293.66M | 217.4M | 153.68M |
Interest Expense | 24.23M | n/a | 303K | n/a | 12K | 71K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 1.18B | 689.52M | 498.77M | 293.66M | 217.4M | 153.68M |
Income Tax Expense | n/a | -753K | -3.52M | -420K | n/a | -371K |
Shares Outstanding (Basic) | 190.13M | 167.74M | 113.15M | 80.63M | 72.81M | 66.6M |
Shares Outstanding (Diluted) | 190.13M | 167.74M | 113.15M | 80.63M | 72.81M | 66.6M |
EPS (Basic) | -5.95 | -3.58 | -3.86 | -3.08 | -2.47 | -1.62 |
EPS (Diluted) | -5.95 | -3.58 | -3.86 | -3.08 | -2.47 | -1.62 |
EBITDA | -1.09B | -589.02M | -430.28M | -239.47M | -179.75M | -101.91M |
EBIT | -1.11B | -600.85M | -439.59M | -249.13M | -187.08M | -108.46M |
Depreciation & Amortization | 16.56M | 11.82M | 9.31M | 9.66M | 7.33M | 6.55M |
Add to Watchlist
Select watchlists to add or remove RVMD